31.12.2013 Views

Graphique 1 - Faculté de Médecine et de Pharmacie de Fès

Graphique 1 - Faculté de Médecine et de Pharmacie de Fès

Graphique 1 - Faculté de Médecine et de Pharmacie de Fès

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

86. Itoh Y, Sekine H, Hosono O, <strong>et</strong> al. Thrombotic thrombocytopenic purpura in<br />

two patients with systemic lupus erythematosus: clinical significance of<br />

antiplatel<strong>et</strong> antibodies. Clin Immunol Immunopathol 1990;57:125–136.<br />

87. Miyamura T, Watanabe H, Takahama S, Sonomoto K, Nakamura M, Ando H, Minami<br />

R, Yamamoto M, Suematsu E.Thrombotic thrombocytopenic purpura in patients<br />

with systemic lupus erythematosus. Nihon Rinsho Meneki Gakkai Kaishi. 2008 Jun;<br />

31(3): 159-65.<br />

88. Levy GG, Motto DG, Ginsburg G. ADAMTS 13 turns 3. Blood 2005;106:11-7.<br />

89. Kwok SK, Ju JH, Cho CS, Kim HY, Park SH. Thrombotic thrombocytopenic<br />

purpura in systemic lupus erythematosus: risk factors and clinical outcome: a<br />

single centre study. Lupus 2009 Jan; 18 (1):16-21.<br />

90. Regan M, Lackner H, Karpatkin S. Platel<strong>et</strong> function and coagulation profile in<br />

lupus erythematosus: studies in 50 patients. Ann Intern Med 1974;81:462–<br />

468.<br />

91. Dorsch CA, Meyerhoff J. Mechanisms of abnormal platel<strong>et</strong> aggregation in systemic<br />

lupus erythematosus. Arthritis Rheum 1982;25: 966–973.<br />

92. Kanai H, Tshuchida A, Yano S, <strong>et</strong> al. Intraplatel<strong>et</strong> and urinary serotonin<br />

concentrations in systemic lupus erythematosus with reference to its clinical<br />

manifestations. J Med 1989;20:371–377.<br />

93. Parbtani A, Frampton G, Yewdall V, <strong>et</strong> al. Platel<strong>et</strong> and plasma serotonin in<br />

glomerulonephritis III. The nephritis of systemic lupus erythematosus. Clin Nephrol<br />

1980;14:164–172.<br />

94. Kanai H, Tshuchida A, Yano S, <strong>et</strong> al. Intraplatel<strong>et</strong> and urinary serotonin<br />

concentrations in systemic lupus erythematosus with reference to its clinical<br />

manifestations. J Med 1989;20:371–377.<br />

95. Meyerhoff J, Dorsch CA. Decreased platel<strong>et</strong> serotonin levels in systemic lupus<br />

erythematosus. Arthritis Rheum 1981;24:1495–1500.<br />

96. Weiss HG, Rosove MH, Lages BA, <strong>et</strong> al. Acquired storage pool <strong>de</strong>ficiency with<br />

increased platel<strong>et</strong>-associated IgG. Am J Med 1980;69: 711–717.<br />

97. Ginsberg HM, O'Malley M. Serum factors releasing serotonin from normal platel<strong>et</strong>s:<br />

relation to the manifestation of systemic lupus erythematosus. Ann Intern Med<br />

1977;87:564–569.<br />

98. T<strong>et</strong>ta C, Bussolino F, Mo<strong>de</strong>na V, <strong>et</strong> al. Release of platel<strong>et</strong>-activity factor in<br />

systemic lupus erythematosus. Int Arch Allergy Immunol 1990;91:244–256.<br />

99. Clark WF, Lewis ML, Cameron JS, <strong>et</strong> al. Intrarenal platel<strong>et</strong> consumption in the<br />

diffuse proliferative nephritis of systemic lupus erythematosus. Clin Sci Mol<br />

Med 1975;49:247–252.<br />

200

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!